Avomeen, Daré Partner to Accelerate Daré’s Pipeline

Daré Bioscience, Inc. and Avomeen, an independent contract research, development, and manufacturing organization, have signed an agreement under which Avomeen will provide contract product development laboratory services with a team to support the advancement of Daré’s innovative pipeline of investigational products designed to address persistent unmet needs in women’s health.  The partnership model aims to enable Daré to leverage Avomeen’s scientific expertise, including advanced instrumentation and development techniques, and accelerate development of key programs in a capital-efficient manner.

Daré and Avomeen are currently collaborating on development-stage programs, including Ovaprene, an investigational hormone-free, monthly contraceptive, and intend to expand their partnership to include more programs in Daré’s women’s health pipeline. Avomeen will develop customized protocols, test methods, and formulations with processes tailored to unique product requirements and specifications. This capability aligns with Daré’s portfolio of potential first-in-category products, which often require a customized approach to method development.

Avomeen will be Daré’s preferred provider of product development laboratory services for an initial three-year period. In exchange for receiving that exclusive service provider status, Avomeen will assemble operating and oversight teams committed to the partnership and provide a preferred discounted pricing structure and, if volume reaches designated levels, will also provide scientific personnel dedicated exclusively to supporting Daré’s development programs covered by the agreement.